Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended the...
false000167181800016718182023-05-122023-05-12 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SEC FILE NUMBER: 001-39575 CUSIP NUMBER: 68236R103 FORM...
false000167181800016718182023-05-022023-05-02 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
YestrueNoYes--12-310001671818NoFY00016718182022-01-012022-12-3100016718182023-03-2000016718182022-06-30xbrli:sharesiso4217:USD ...
false000167181800016718182023-04-292023-04-29 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
--12-310001671818three yearsfalseFY0001671818us-gaap:LeaseholdImprovementsMember2022-12-310001671818srt:Maximu...
0001671818false00016718182023-03-242023-03-24 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
Reprioritized product portfolio to focus on IV-administered, self-amplifying RNA medicinesOn track to submit...
false000167181800016718182023-03-142023-03-14 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER...
Research collaboration leverages Oncorus’ proprietary ionizable amines, PEG lipids, LNP formulations, process...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지